Old Web
English
Sign In
Acemap
>
authorDetail
>
Rebecca Wood
Rebecca Wood
University of Washington
Oncology
Medicine
Internal medicine
Phases of clinical research
Nab-paclitaxel
3
Papers
2
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A Phase II study of nab-Paclitaxel (nab-P) in patients with advanced non-small cell lung cancer with EGFR mutations after frontline tyrosine kinase inhibitor therapy.
2021
Cancer treatment and research
Christina S. Baik
Sylvia Lee
Kitty Cook
Sarah G. Wallace
Rebecca Wood
Rafael Santana-Davila
Laura Quan Man Chow
Cristina P. Rodriguez
Keith D. Eaton
Renato G. Martins
Show All
Source
Cite
Save
Citations (0)
P3.02b-061 A Phase II Study of Nab-Paclitaxel (Nab-P) in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) with EGFR Mutations: Topic: EGFR Clinical
2017
Journal of Thoracic Oncology
Christina S. Baik
Bernardo Goulart
Katherine Nguyen
Sylvia M. Lee
Keith D. Eaton
Laura Quan Man Chow
Cristina P. Rodriguez
Rafael Santana-Davila
Rebecca Wood
Renato Martins
Show All
Source
Cite
Save
Citations (0)
Phase II trial of eribulin for recurrent or metastatic salivary gland cancers.
2016
Journal of Clinical Oncology
Keith D. Eaton
Bernardo Goulart
Rafael Santana-Davila
Laura Quan Man Chow
Rebecca Wood
Cristina P. Rodriguez
Christina S. Baik
Renato Martins
Show All
Source
Cite
Save
Citations (2)
1